Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-01-12 Purchase | 2026-01-14 6:20 pm | Aktis Oncology Inc. | AKTS | Foley Todd Director 10% Owner | 232,870 | $18 | $4,191,660 | 4,235,403 (Indirect) | View |
| 2026-01-12 Purchase | 2026-01-14 6:19 pm | Aktis Oncology Inc. | AKTS | MPM BIOVENTURES 2018 L.P. EVNIN LUKE MPM BIOVENTURES 2018 (B) L.P. MPM BioVentures 2018 LLC MPM BioVentures 2018 GP LLC MPM ASSET MANAGEMENT INVESTORS BV2018 LLC MPM ONCOLOGY INNOVATIONS FUND LP MPM Oncology Innovations Fund GP LLC 10% Owner | 1,112,777 | $18 | $20,029,986 | 10,260,064 (Indirect) | View |
| 2026-01-12 Purchase | 2026-01-14 6:17 pm | Aktis Oncology Inc. | AKTS | GADICKE ANSBERT MPM ASSET MANAGEMENT LLC Oncology Impact Private Investment Fund 2 L.P. 10% Owner | 1,112,777 | $18 | $20,029,986 | 10,260,064 (Indirect) | View |
| 2026-01-12 Purchase | 2026-01-12 8:28 pm | Aktis Oncology Inc. | AKTS | EcoR1 Capital LLC NODELMAN OLEG Director | 2,222,222 | $18 | $39,999,996 | 1,398,717 (Indirect) | View |
| 2026-01-12 Purchase | 2026-01-12 5:10 pm | Aktis Oncology Inc. | AKTS | Vida Ventures II LLC VIDA VENTURES II-A LLC 10% Owner | 835,000 | $18 | $15,030,000 | 157,387 (Indirect) | View |
| 2026-01-12 Purchase | 2026-01-12 5:00 pm | Aktis Oncology Inc. | AKTS | Kim Helen Susan Director 10% Owner | 835,000 | $18 | $15,030,000 | 157,387 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2026-01-15 06:01 am | N/A N/A | Aktis Oncology Inc. | AKTS | ELI LILLY & Co 10% Owner | 0 | $0 | 6,344,114 (Direct) | View |
| 2026-01-12 Conversion | 2026-01-14 6:20 pm | N/A N/A | Aktis Oncology Inc. | AKTS | Foley Todd Director 10% Owner | 19,229,806 | $0 | 4,235,403 (Indirect) | View |
| 2026-01-12 Conversion | 2026-01-14 6:19 pm | N/A N/A | Aktis Oncology Inc. | AKTS | MPM BIOVENTURES 2018 L.P. EVNIN LUKE MPM BIOVENTURES 2018 (B) L.P. MPM BioVentures 2018 LLC MPM BioVentures 2018 GP LLC MPM ASSET MANAGEMENT INVESTORS BV2018 LLC MPM ONCOLOGY INNOVATIONS FUND LP MPM Oncology Innovations Fund GP LLC 10% Owner | 42,305,578 | $0 | 10,260,064 (Indirect) | View |
| 2026-01-12 Conversion | 2026-01-14 6:17 pm | N/A N/A | Aktis Oncology Inc. | AKTS | GADICKE ANSBERT MPM ASSET MANAGEMENT LLC Oncology Impact Private Investment Fund 2 L.P. 10% Owner | 42,305,578 | $0 | 10,260,064 (Indirect) | View |
| 2026-01-12 Conversion | 2026-01-12 8:28 pm | N/A N/A | Aktis Oncology Inc. | AKTS | EcoR1 Capital LLC NODELMAN OLEG Director | 17,553,659 | $0 | 1,398,717 (Indirect) | View |
| 2026-01-12 Conversion | 2026-01-12 5:10 pm | N/A N/A | Aktis Oncology Inc. | AKTS | Vida Ventures II LLC VIDA VENTURES II-A LLC 10% Owner | 23,994,212 | $0 | 157,387 (Indirect) | View |
| 2026-01-12 Conversion | 2026-01-12 5:00 pm | N/A N/A | Aktis Oncology Inc. | AKTS | Kim Helen Susan Director 10% Owner | 23,994,212 | $0 | 157,387 (Indirect) | View |
| 2026-01-12 Conversion | 2026-01-12 5:00 pm | N/A N/A | Aktis Oncology Inc. | AKTS | Segal Lloyd Mitchell Director | 94,318 | $0 | 19,631 (Indirect) | View |
Ownership | 2026-01-08 9:19 pm | N/A 2035-12-11 | Aktis Oncology Inc. | AKTS | Kuvalanka Kyle D. Chief Financial Officer | 0 | $0 | 501,849 (Direct) | View |
Ownership | 2026-01-08 9:09 pm | N/A N/A | Aktis Oncology Inc. | AKTS | Kim Helen Susan Director 10% Owner | 0 | $0 | 5,032,078 (Indirect) | View |
Ownership | 2026-01-08 9:08 pm | N/A 2030-11-23 | Aktis Oncology Inc. | AKTS | Herrmann Ken Director | 0 | $0 | 146,416 (Direct) | View |
Ownership | 2026-01-08 9:05 pm | N/A N/A | Aktis Oncology Inc. | AKTS | GADICKE ANSBERT MPM ASSET MANAGEMENT LLC Oncology Impact Private Investment Fund 2 L.P. 10% Owner | 0 | $0 | 9,147,287 (Indirect) | View |
Ownership | 2026-01-08 9:05 pm | N/A N/A | Aktis Oncology Inc. | AKTS | Segal Lloyd Mitchell Director | 0 | $0 | 120,047 (Indirect) | View |
Ownership | 2026-01-08 9:05 pm | N/A N/A | Aktis Oncology Inc. | AKTS | RODEN MATTHEW President and CEO | 0 | $0 | 2,241,407 (Direct) | View |
Ownership | 2026-01-08 9:04 pm | N/A N/A | Aktis Oncology Inc. | AKTS | MPM BIOVENTURES 2018 L.P. MPM BIOVENTURES 2018 (B) L.P. MPM ASSET MANAGEMENT INVESTORS BV2018 LLC MPM BioVentures 2018 GP LLC MPM BioVentures 2018 LLC MPM ONCOLOGY INNOVATIONS FUND LP MPM Oncology Innovations Fund GP LLC EVNIN LUKE 10% Owner | 0 | $0 | 9,147,287 (Indirect) | View |
Ownership | 2026-01-08 9:03 pm | N/A 2032-10-30 | Aktis Oncology Inc. | AKTS | Ron-Bigger Shulamit Chief Operating Officer | 0 | $0 | 536,295 (Direct) | View |
Ownership | 2026-01-08 9:03 pm | N/A N/A | Aktis Oncology Inc. | AKTS | Foley Todd Director 10% Owner | 0 | $0 | 4,040,399 (Indirect) | View |
Ownership | 2026-01-08 9:02 pm | N/A N/A | Aktis Oncology Inc. | AKTS | Feldman Paul L Chief Scientific Officer | 0 | $0 | 551,459 (Direct) | View |
Ownership | 2026-01-08 9:02 pm | N/A 2034-06-30 | Aktis Oncology Inc. | AKTS | Czibere Akos Chief Medical Officer | 0 | $0 | 520,928 (Direct) | View |
Ownership | 2026-01-08 9:00 pm | N/A 2035-10-08 | Aktis Oncology Inc. | AKTS | Sherman Michael A. Director | 0 | $0 | 93,846 (Direct) | View |
Ownership | 2026-01-08 8:57 pm | N/A 2035-01-14 | Aktis Oncology Inc. | AKTS | Thistle Mary Director | 0 | $0 | 93,846 (Direct) | View |
Ownership | 2026-01-08 8:49 pm | N/A N/A | Aktis Oncology Inc. | AKTS | EcoR1 Capital LLC NODELMAN OLEG Director 10% Owner | 0 | $0 | 3,691,525 (Indirect) | View |
Ownership | 2026-01-08 8:41 pm | N/A N/A | Aktis Oncology Inc. | AKTS | Vida Ventures II LLC VIDA VENTURES II-A LLC 10% Owner | 0 | $0 | 4,994,212 (Indirect) | View |